logo

Earnings Review: January 7, 2009
By: iStockAnalyst   Wednesday, January 07, 2009 8:20 PM

Vote for next session
The next market session will close:

(By Salman - iStockAnalyst Writer)Late on Wednesday, home-furnishings retailer,  Bed Bath & Beyond Inc. (NASDAQ: BBBY) announced that third quarter net income plunged about 37% to $87.7 million or 34 cents a share from $138.2 million or 52 cents a share in the year ago quarter. Net sales fell 0.7% to $1.783 billion from $1.795 billion in the third quarter of 2007. Same store sales declined 5.6%, compared to an increase of 0.8% in the same period in 2007. Analysts on average expected the company to report earnings of 33 cents a share for the quarter on revenue of $1.79 billion. Looking ahead, for the fourth quarter, the company expects earnings in the range of 40 cents to 46 cents a share. For the full year, the company expects to report earnings of $1.50 to $1.56 a share. Analysts on average currently expect earnings of 49 cents a share for the fourth quarter, and earnings of $1.58 a share for the full year.

Christopher & Banks Corp. (NYSE: CBK) posted a third-quarter net loss of $1.4 million or 4 cents a share, compared to net income of $10.2 million or 29 cents a share in the corresponding quarter last year. Revenue dropped to $143.0 million from $155.2 million in the same quarter last year. Consensus estimates were for a loss 9 cents a share for the quarter on revenue of $133.04 million. President and Chief Executive Officer Lorna Nagler said in a statement “While the challenging economic environment continues to impact our fiscal 2009 results, we are seeing evidence that a number of the initiatives we have been working on should result in a stronger and more profitable company when conditions normalize. For now, inventory and expense controls, and maintaining positive cash flow are our highest priorities. We are fortunate to have a strong balance sheet that puts us in a solid position to weather this storm. At the end of the third quarter, we had $90 million of cash and investments and no debt.”

Blood-testing products maker Immucor Inc. (NASDAQ: BLUD) reported that its second quarter net earnings rose marginally to $17.3 million or 24 cents a share from $16.2 million or 23 cents a share in the comparable quarter in 2007. Revenue jumped 18% to $73.0 million from $61.9 million in the prior year quarter. Analysts on average had projected earnings of 21 cents a share for the quarter on revenue of $71.07 million. Looking ahead, for fiscal year 2009, the company raised its earnings guidance to a range of 97 cents to $1.02 a share from its previous outlook of 94 cents to 98 cents a share. The company continues to expect revenue of $292 million to $300 million. Street analysts currently expect earnings of 98 cents a share for the full year on revenue of $297.24 million.

Next Page >>123

(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by iStockAnalyst



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia